Published in Acta Psychiatr Scand on June 25, 2009
Antipsychotics, mood stabilisers, and risk of violent crime. Lancet (2014) 4.25
Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open (2014) 1.83
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf (2013) 1.24
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One (2013) 1.13
Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. PLoS One (2011) 1.10
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D (2015) 1.04
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health (2013) 1.03
Are commonly used psychoactive medications associated with lower urinary tract symptoms? Eur J Clin Pharmacol (2011) 0.86
Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013. Eur Child Adolesc Psychiatry (2015) 0.81
Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice. Schizophr Bull (2013) 0.81
Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice. Bipolar Disord (2015) 0.79
Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers. Br J Clin Pharmacol (2012) 0.78
Changes in antipsychotic prescription practice at University Hospital in Belgrade, Serbia: 2009 vs. 2004. Acta Psychiatr Scand (2011) 0.78
Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study. PLoS One (2013) 0.78
Diffusion of antipsychotics in the US And French markets, 1998-2008. Psychiatr Serv (2013) 0.77
A naturalistic study of suicidal adolescents treated with an SSRI: suicidal ideation and behavior during 3-month post-hospitalization period. Asian J Psychiatr (2014) 0.77
Atypical antipsychotics and effects on feeding: from mice to men. Psychopharmacology (Berl) (2016) 0.76
Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study. BMC Psychiatry (2014) 0.75
Magic bullets for mental disorders: the emergence of the concept of an "antipsychotic" drug. J Hist Neurosci (2013) 0.75
Evidence review and clinical guidance for the use of ziprasidone in Canada. Ann Gen Psychiatry (2013) 0.75
Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series. Glob Adv Health Med (2015) 0.75
A retrospective study of antipsychotic drug switching in a pediatric population. BMC Psychiatry (2013) 0.75
Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013. Isr J Health Policy Res (2016) 0.75
Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance. Ther Adv Psychopharmacol (2013) 0.75
The antipsychotic story: changes in prescriptions and overdose without better safety. Br J Clin Pharmacol (2016) 0.75
Influence of socioeconomic status on antipsychotic prescriptions among youth in France. BMC Psychiatry (2017) 0.75
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics. Neuropsychiatr Dis Treat (2014) 0.75
An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists. Int J Endocrinol (2015) 0.75
759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment. Clin Pharmacol Biopharm (2013) 0.75
Risk Factors for Inpatient Psychiatric Readmission: Are There Gender Differences? Community Ment Health J (2015) 0.75
Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. J Endocrinol Invest (2017) 0.75
The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004-2015. Eur J Clin Pharmacol (2017) 0.75
Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association. BJPsych Bull (2017) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ (2000) 2.49
[Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. Therapie (1985) 2.41
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol (1998) 2.02
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol (1997) 2.02
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol (2000) 2.01
Benzodiazepines and hip fractures in elderly people: case-control study. BMJ (2001) 1.85
Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol (1997) 1.78
Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol (1998) 1.78
[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]. Therapie (1999) 1.72
Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med (2003) 1.67
Spontaneous reporting: how many cases are required to trigger a warning? Br J Clin Pharmacol (1991) 1.55
Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patients. Acta Psychiatr Scand (2003) 1.48
CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J Immunol (1998) 1.40
Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials. Clin Exp Rheumatol (2005) 1.39
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol (2001) 1.19
Power and weakness of spontaneous reporting: a probabilistic approach. J Clin Epidemiol (1992) 1.17
CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur J Immunol (1995) 1.16
4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol (1999) 1.09
Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. J Clin Epidemiol (1996) 1.08
Sample size calculations for single group post-marketing cohort studies. J Clin Epidemiol (1994) 1.06
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. Eur J Immunol (1994) 1.06
Comparison of 500 spontaneous and 500 published reports of adverse drug reactions. Eur J Clin Pharmacol (1990) 1.00
Is reporting rate a good predictor of risks associated with drugs? Br J Clin Pharmacol (1999) 0.99
Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists. Br J Clin Pharmacol (2000) 0.95
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf (2007) 0.94
The link between sunshine and phototoxicity of sparfloxacin. Br J Clin Pharmacol (2000) 0.89
Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates. Pharmacoepidemiol Drug Saf (2002) 0.88
Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study. Clin Pharmacol Ther (2010) 0.87
What are the risks of third-generation oral contraceptives? Are third-generation oral contraceptives safe? Hum Reprod (1996) 0.87
Temporal trends in spontaneous reporting of unlabelled adverse drug reactions. Br J Clin Pharmacol (1997) 0.86
Patterns of risperidone prescription: a utilization study in south-west France. Acta Psychiatr Scand (2004) 0.86
Adverse drug reactions: physicians' opinions versus a causality assessment method. Eur J Clin Pharmacol (1994) 0.85
The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf (2007) 0.84
Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. Br J Clin Pharmacol (2001) 0.82
Benzodiazepine use and wine consumption in the French elderly. Br J Clin Pharmacol (2001) 0.82
Antipsychotic use patterns in persons initially treated with mood stabilizers: a naturalistic study. Pharmacopsychiatry (2009) 0.82
Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe. Int J Clin Pharmacol Ther (2002) 0.82
Abuse of prescription medicines in southwestern France. Ann Pharmacother (1997) 0.81
The role of pharmacoepidemiology in pharmacovigilance: a conference at the 6th ESOP Meeting, Budapest, 28 September 1998. Pharmacoepidemiol Drug Saf (1999) 0.81
Incidence of serious adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther (2001) 0.81
Characteristics associated with use of homeopathic drugs for psychiatric symptoms in the general population. Eur Psychiatry (2011) 0.81
Are generic drugs really inferior medicines? Clin Pharmacol Ther (2010) 0.81
[Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey]. Encephale (2007) 0.80
Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice. Therapie (2000) 0.80
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study. Clin Pharmacol Ther (2010) 0.80
[The French system of evaluation of dependence: establishment in a legal system]. Therapie (2001) 0.80
European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study. Eur J Clin Pharmacol (1998) 0.80
Modern epidemiology: forward to the 18th century! Lancet (1999) 0.79
[A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder]. Encephale (2005) 0.79
[Incidence and prevalence of adverse drug reactions]. Presse Med (2000) 0.78
Vaccinations and multiple sclerosis. N Engl J Med (2001) 0.78
Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model. Psychol Med (2008) 0.78
Neuropathy associated with leflunomide: a case series. Ann Rheum Dis (2005) 0.78
LAG-3 does not define a specific mode of natural killing in human. Immunol Lett (1998) 0.78
[Methods for studying the adverse effects of drugs. II. Profile and comparison of 5 methods for establishing causality]. Therapie (1984) 0.78
Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.77
In vitro-induced human airway hyperresponsiveness to bradykinin. Eur Respir J (1998) 0.77
[Information centers on undesirable effects of drugs: also on alerting function]. Therapie (1987) 0.77
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin Pharmacol Ther (2001) 0.76
Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population. Acta Psychiatr Scand (2007) 0.76
[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study]. Ann Endocrinol (Paris) (2008) 0.76
[Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods]. Therapie (1986) 0.75
Impact of duration of antidepressant treatment on the risk of occurrence of a new sequence of antidepressant treatment. Pharmacopsychiatry (2011) 0.75
[Users of a regional center of pharmacovigilance]. Therapie (1994) 0.75
[Activities of a regional drug monitoring center. What to evaluate, how and for what purpose]. Therapie (1988) 0.75
[Where can we find French data for pharmacoepidemiology? A few thoughts]. Rev Epidemiol Sante Publique (2007) 0.75
[Computerized data processing in the Pharmacovigilance Center of Bordeaux-Aquitaine. Analysis of clientele of the Center]. Therapie (1991) 0.75
[Record linkage: a technic in drug surveillance]. Therapie (1987) 0.75
Sample size calculations for risk equivalence testing in pharmacoepidemiology. J Clin Epidemiol (2000) 0.75
[Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers]. Encephale (2012) 0.75
[Adverse effects of orphan drugs]. Therapie (1987) 0.75
[Exception drugs status: specific characteristics and the role in the proper use of drugs]. Rev Epidemiol Sante Publique (2013) 0.75
[Dextropropoxyphene-paracetamol and general convulsive crisis: case report]. Therapie (1999) 0.75
Efficiency of medical journals for pharmacovigilance. Lancet (1993) 0.75
[Substitution treatment for opiate dependence: survey of community pharmacies in Aquitaine]. Therapie (1999) 0.75
[Regional Centers of Pharmacovigilance: a complementary source of efficiency]. Therapie (1998) 0.75
[Pharmacovigilance and practical medicine. Pragmatic approach in therapeutic counseling for pregnant women]. Therapie (1987) 0.75
Natural character posing from a large motion database. IEEE Comput Graph Appl (2014) 0.75
[Guide for the imputability of drug-induced hepatitis]. Therapie (1985) 0.75
[Public health networks: practical aspects and contribution to clinical research. Round table no. 2. XV]. Therapie (2001) 0.75
[Benzodiazepine consumption: survey of community pharmacies in Aquitaine]. Therapie (2001) 0.75
[Demonstration of portocaval encephalopathy in children]. Psychiatr Enfant (1978) 0.75